Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x100px
Financing › Details

SHS Capital–SEVERAL: investment, 202309 final closing of SHS VI fund adding ca €50 after first close bringing total fund size to €270m

 

Period Period 2023-09-13
  Predecessor SHS Capital–SEVERAL: investment, 202207 first closing at over €220m of SHS VI fund with EIF + Realdania + Helsana HealthInvest + LBBW et al.
Organisations Money taker SHS VI fund
  Group SHS Capital (Group)
  Money source SEVERAL
Products Product SHS VI fund
  Product 2 healthcare
     

SHS Gesellschaft für Beteiligungsmanagement mbH. (9/13/23). "Press Release: Healthcare Specialist SHS Capital Announces Final Closing of Its Oversubscribed Sixth Fund Generation Totaling EUR 270 Million". Tübingen.

> The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation

> The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling the predecessor fund’s size

> The new fund will invest in European growing healthcare companies and allocates between EUR 10 and 40 million per transaction

> The fund has already conducted four transactions between First and Final Closing

Tübingen, Germany / 13.09.2023

SHS Capital has raised ca. EUR 270 million for their sixth fund generation. Due to high demand, the originally targeted fund volume of EUR 200 million could significantly be exceeded and is thus more than double the predecessor fund’s size. The investment focus of the new fund SHS VI is on growing European healthcare companies.

The new fund aims for ten to fifteen investments in the form of both majority and minority positions. The fund’s investment amount is EUR 10 to 40 million. Together with LPs and other investors, transaction values up to EUR 150 million can be realized. SHS only invests in companies already generating significant revenues, are on a growth path and aim to become European healthcare champions. SHS can support this through its large network in the healthcare sector, its long-standing industry experience, and extensive market knowledge. Since the First Closing of the fund last summer, four investments have already been made from the new fund. Thus, SHS has realized a total of 13 investments and 13 exits since 2020.

Amongst the investors of SHS VI are fund of funds, insurance companies, pension funds, foundations, family offices, banks, healthcare corporates, church investors, and entrepreneurs. Furthermore, the SHS investment team itself has invested significantly.

“The healthcare sector is an indispensable sector and therefore offers numerous exciting opportunities for investments. With us, investors have the chance to participate in the development of this growth market. Our track record shows attractive returns for our investors and at the same time contribute to improving the healthcare system through innovations and optimizing patient care,” explains Manfred Ulmer-Weber, Managing Partner at SHS.

“The volume of the new fund has significantly exceeded our expectations and confirmed our positioning as the leading private equity healthcare specialist in Germany, and thus the largest European healthcare market. We are very pleased that many of SHS’s investors in previous funds have also invested in our new fund, in some cases with significantly increased subscriptions. In addition, we were able to further internationalize our pool of investors and expand it with renowned addresses. We would like to thank our investors for their trust,” says SHS Managing Partner Sascha Alilovic.


About SHS Gesellschaft für Beteiligungsmanagement mbH:

SHS Capital is a private equity provider founded in 1993 that invests in healthcare companies in Europe. The focus of the investments is on expansion financing, shareholder changes and succession situations. “Building European Healthcare Champions” is the investment philosophy according to which SHS finances and develops portfolio companies. The German investor takes both minority and majority stakes. The national and international investors in SHS funds include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team. The equity or equity-like investment of the AIF is up to € 40 million. Volumes in excess of this can be realised with a network of co-investors. In its investment decisions, SHS attaches great importance to the consideration of ESG aspects and has therefore committed itself to the guidelines of the UN PRI. SHS is currently investing from its sixth fund, which was launched in 2022 and has a volume of ca. € 270 million.

More information at: https://www.shs-capital.eu


Interested in receiving regular updates on SHS? Subscribe to our newsletter and follow us on LinkedIn


Press contact:

Sarah Stelzer
SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstraße 12
72072 Tübingen
sas@shs-capital.eu

   
Record changed: 2024-02-21

Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px

More documents for SHS Capital (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top